Hemovigilance in the United States of America

Vox Sanguinis

Volumn 74, Issue SUPPL. 2, 1998, Pages 447-455

  Menitove, Jay E ^a  

^a Division of New York Blood Center Enterprises   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD BANK; BLOOD TRANSFUSION; CONFERENCE PAPER; GOOD MANUFACTURING PRACTICE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; UNITED STATES;

EID: 0031820496     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1998.tb05455.x     Document Type: Conference Paper

References (68)

1. Williamson LM, Love EM: Reporting Serious Hazards of Transfusion: The SHOT Program. Transfusion Medicine Reviews 1998;12:28-35.
2. Morel P, Hervé P: Surveillance of Blood Transfusion Safety. Transfusion Medicine Reviews (in press).
3. Food and Drug Administration: Guideline For Quality Assurance In Blood Establishments 1995.
4. Cooper ES: Accreditation Information Manual American Association of Blood Banks 1997.
5. Fresh-Frozen Plasma Indications and Risks. JAMA 1995; 253:551-553 NIH Consensus Conference.
6. Platelet Transfusion Therapy. JAMA 1987;257:1777-1780 NIH Consensus Conference.
7. Preoperative Red Blood Cell Transfusion. JAMA 1988;260:2700-2703 NIH Consensus Conference.
8. Practice Guidelines Task Force of the College of American Pathologists: Practice Parameter for the Use of Fresh-Frozen Plasma, Cryoprecipitate, and Platelets. JAMA 1994;271:777-781.
9. American College of Physicians: Practice Strategies for Elective Red Blood Cell Transfusion. Annal Intern Med 1992;116:403-406.
10. American Society of Anesthesiologists Task Force on Blood Component Therapy: Practice Guidelines for Blood Component Therapy. Anesthesiology 1996;84:732-47.
11. United States General Accounting Office: Blood Supply FDA Oversight and Remaining Issues of Safety, 1997.
12. Centers for Biologics Evaluation and Research, A Plan For Reinventing PDA's Ability to Optimize Compliance of Regulated Biologies Industries 1997.
13. Food and Drug Administration: Biological Products; Reporting of Errors and Accidents in Manufacturing. Federal Register 1997;62:49642-49648.
14. Sazama K: Current Good Manufacturing Practices for Transfusion Medicine. Transfusion Medicine Reviews 1996;10:286-295.
15. Busch MP, Operskalski EA, Mosley JW, Stevens CE, Schiff ER, Kleinman SH, Lee H, Lee M, Harris M: Epidemiologic background and long-term course of disease in human immunodeficiency virus type 1-infected blood donors identified before routine laboratory screening. Transfusion Safety Study Group. Transfusion 1994;34:858-864.
16. The Trial to Reduce Alloimmunization to Platelets Study Group: Leukocyte Reduction and Ultraviolet B Irradiation of Platelets To Prevent Alloimmunization and Refractoriness to Platelet Transfusions. N Engl J Med 1997;337:1861-68.
17. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ: The Risk of Transfusion-Transmitted Viral Infections. N Engl J Med 1996;334:1685-1690.
18. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, DiBisceglie A, Hoofnagle J, Shih JW, Kaslow R, Ness P, Alter HJ: Routes of Infection, Vermia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infection. N Engl J Med 1996;334:1691-1696.
19. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JWK, Kim JP: The Incidence of Transfusion-Associated Hepatitis G Virus Infection and Its Reaction to Liver Disease. New Engl J Med 1997;336:747-754.
20. Centers for Disease Control and Prevention: Malaria Surveillance-United States, 1994. MMWR 1997;46:No.SS-5.
21. Alter MJ, Gallagher M, Morris T, Mover LA, Meeks EL, Krawczynski K, Kim JP, Margolis HS: Acute Non-A-E Hepatitis in The United States and the Role of Hepatitis G Virus Infection. N Engl J Med 1997;336:741-746.
22. Centers for Disease Control and Prevention: Identification of HIV-1 Group O Infection Los Angeles County, California, 1996. MMWR 1996;45:561-565.
23. AABB, ARC, CDC, DoD: Assessment of the Frequency of Blood Component Bacterial Contamination Associated with Transfusion Reaction (BaCon Study) 1997.
24. Centers for Disease Control and Prevention: Adverse Ocular Reactions Following Transfusions - United States, 1997-1998. MMWR 1998;47:49-50.
25. th 1997.
26. Schmidt PJ: The essential standards. Transfusion 1997;37:1093-1094.
27. Hamlin WB, Duckworth JK: The College of American Pathologists, 1946-1996 Laboratory Accreditation, Arch Pathol Lab Med 1997;121:745-753.
28. DeChristopher PJ: Standard Setting Organizations: How Can We Work Together. The Compendium A Selection of Short Topic Presentations AABB 1997.
29. Joint Commission on Accreditation of Healthcare Organizations: 1998-99 Comprehensive Accreditation Manual for Pathology and Clinical Laboratory Services. Quality Control: 283-351.
30. Belanger AC: Standards Setting Organizations: How Can We Work Together. The Compendium A Selection of Short Topic Presentations AABB 1997.
31. Tomasulo PA, Lenes BA, Noto TA, Klein HG, Menitove JE: Automatic special case consultations in transfusion medicine. Transfusion 1986;26:186-193.
32. Bracey AW, Radovancevic R, Radovancevic B, McAllister HA, Vaughn WK, Cooley DA: Blood use in patients undergoing repeat coronary artery bypass graft procedures: multivariate analysis. Transfusion 1995;35:850-854.
33. Surgenor DM, Churchill WH, Wallace EL, Rizzo RJ, Chapman RH, McGurk S, Bertholf MF, Goodnough LT, Kao KJ, Koerner TAW, Olson JD, Woodson RJD: Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: the Collaborative Hospital Transfusion Study. Transfusion 1996;36:521-532.
34. Herbert PC, Schweitzer I, Calder L, Blajchman M, Giulivi A: Review of the clinical practice literature on allogenic red blood cell transfusion. Can Med Assoc J 1997;156(11 Suppl):S9-S26.
35. Brown RL, Brown RL, Edwards JA, Nutz JF: Variation in a Medical Faculty's Decision to Transfuse: Implications for Modifying Blood Product Utilization. Medical Care 1992;30:1083-1093.
36. Pisciotto PT, Benson K, Hume H, Glassman AB, Oberman H, Popovsky M, Hines D, Anderson K: Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients. Transfusion 1995;35:498-502.
37. Goodnogh LT, Johnson MFM, Toy TCY, and the Transfusion Medicine Academic Award Group: The Variability of Transfusion Practice in Coronary Artery Bypass Surgery. JAMA 1991;265:86-90.
38. Snyder AJ, Gottschall L, Menitove JE: Why is fresh-frozen plasma transfused?. Transfusion 1986;26:107-112.
39. Mair B, Agosti SJ, Foulis PR, Hamilton RA, Bensen K: Monitoring for undertransfusion. Transfusion 1996;36:533-535.
40. Evidence-Based Working Group: Evidence-Based Medicine A New Approach to Teaching the Practice of Medicine. JAMA 1992;268:2420-2425.
41. Woolf SH: Practice Guidlines, a Reality in Medicine. Arch Intern Med 1992;152:946-952.
42. Hayward RSA, Wilson MC, Tunis SR, Bass EB, Guyatt GL: User's Guides to the Medical Literature. JAMA 1995;274:570-574.
43. Silberstein LE, Kruskall MS, Stehling LC, Johnston M, Rutman RC, Samia CT, Ramsey G, Eisenstaedt RS: Strategies for the Review of Transfusion Practices. JAMA 1989;262:1993-1997.
44. Stehling L, Luban NLC, Anderson KC, Sayers MH, Long A, Attar S, Leitman SF, Gould SA, Kruskall MS, Goodnough LT, Mines DM: Guidelines for blood utilization review. Transfusion 1994;34:438-448.
45. Calder L, Herbert PC, Carter AO, Graham ID: Review of published recommendations and guidelines for the transfusion of allogeneic red blood cells and plasma. Can Med Assoc J 1997;156(11 Suppl):S1-S8.
46. Goodnough LT, Johnston MFM, Ramsey G, Sayers MH, Eisenstadt RS, Anderson KC, Rutman RC, Silberstetn LE: Guidelines for Transfusion Support in Patients Undergoing Coronary Artery Bypass Grafting. Ann Thorac Surg 1990;50:675-683.
47. Committee Technical Bulletins: Blood component therapy. International Journal of Gynecology & Obstetrics 1995;48:233-238.
48. Spence RK: Surgical Red Blood Cell Transfusion Practice Policies. Am J Surg 1995;170:3S-15S.
49. Cummings JP: Technology Assessment: Red Cell Transfusion Guidelines. OakBrook, IL. University Health System Services Corporation. 1997.
50. Dumont LJ, Dzik WH, Rebulla P, Brandwein H: Practical guidelines for process validation and process control of white cell-reduced blood components: report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT).Transfusion 1996;36:11-20.
51. Mintz PD: Quality Assessment and Improvement of Transfusion Practices. Hematology/ Oncology Clinics of North America 1995;9:219-232.
52. Grindon AJ, Tomasulo PS, Bergin JJ, Klein HG, Miller JD, Mintz PD: The Hospital Transfusion Committee: Guidelines for Improving Practice. JAMA 1985;253:540-543.
53. Shanberge JN: Reduction of fresh-frozen plasma use through a daily survey and education program. Transfusion 1987;27:226-227.
54. McCullough J, Steeper TA, Connelly DP, Jackson B, Huntington S, Scott EP: Platelet Utilization in a University Hospital. JAMA 1988;259:2414-2418.
55. Hamoudi AC, Cecalupo AJ, Wolf ML, Coe SA, Menke JA: The Use of LIS for Blood Usage Review Experience in a Children's Hospital. Am J Clin Pathol 1991;95:389-392.
56. Lepage EF, Gardner RM, Laub RM, Golubjatnikov OK: Improving blood transfusion practice: role of a computerized hospital information system. Transfusion 1992;32:253-259.
57. Silver H, Tahhan HR, Anderson J, Lachman M: A non-computer prospective review of blood and blood component utilization. Transfusion 1992;32:260-265.
58. Rosen NR, Bates LH, Herod G: Transfusion Therapy: improved patient care and resource utilization. Transfusion 1993;33:341-347.
59. Soumerai SB, Salem-Schatz S, Avorn J, Casteris CS, Ross-Degnan D, Popovsky MA: A Controlled Trial of Education Outreach to Improve Blood Transfusion Practice. JAMA 1993;270:961-966.
60. Hasley PB, Lave JR, Kapoor WN: The necessary and the unnecessary transfusion: a critical review of reported appropriateness rates and criteria for red cell transfusions. Transfusion 1994; 34:110-115.
61. Despotis GJ, Grishaber JE, Goodnough LT: The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery. Transfusion 1994:34:290-296.
62. Toy P: Effectiveness of Transfusion Audits and Practice Guidelines. Arch Pathol Lab Med 1994;118:435-437.
63. Goodnough LT: Current Red Blood Cell Transfusion Practices. AACN Clinical Issues 1996;7:212-220.
64. Audet AM, Goodnough LT, Parvin CA: Evaluating the Appropriateness of Red Blood Cell Transfusions: the Limitations of retrospective Medical Record Reviews. International Journal for Quality in Health Care 1996;8:41-49.
65. Lam H, Schweitzer SO, Petz L, Kanter M H, Bernstein DA, Brauer S, Pascual DV, Myhre BA, Shulman IA, Sun GW: Effectiveness of a prospective physician self-audit transfusion-monitoring system. Transfusion 1997;37:557-584.
66. Smith EN, Holland PV, Holliman SM, Fuller MJ: Staff costs associated with the implementation of a comprehensive compliance program in a community blood center. Transfusion 1995;35:679-682.
67. McCullough J: The Continuing Evolution of the Nation's Blood Supply System. Am J Clin Pathol 1996;105:689-695.
68. AuBuchon JP, Birkmeyer JD, Busch MP: Safety of the Blood Supply in the United States-, Opportunities and Controversies, Annals of Internal Medicine 1997;127:904-909.